

Cataract Surgery Devices Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The cataract surgery devices market is experiencing robust growth, driven by an aging population and advancements in technology. Valued at approximately $6 billion in 2023, the market is projected to expand at a CAGR of over 5% through 2030. Key factors include rising awareness and increasing procedural volumes globally.
◍ Abbott Laboratories
◍ Novartis AG
◍ Carl Zeiss Meditec AG
◍ Essilor International S.A.
◍ HAAG-Streit Holding AG
◍ Johnson & Johnson
◍ Nidek Co., Ltd.
◍ Topcon Corporation
The cataract surgery devices market is competitive, with major players including Abbott Laboratories, Novartis AG, and Johnson & Johnson. These companies innovate and offer advanced surgical tools, enhancing patient outcomes. Their contributions drive market growth, supported by notable revenues, e.g., Abbott $43.1B; Novartis $48.5B; Johnson & Johnson $93.7B.
◍ Valeant Pharmaceuticals International, Inc.
◍ Ziemer Ophthalmic Systems AG
◍ HumanOptics AG
◍ PhysIOL S.A.
◍ Calhoun Vision Cente
◍ EyeKon Medical, Inc.
◍ Allergan Inc.
◍ VisionCare Ophthalmic Technologies, Inc.
◍ Essilor International S.A.
◍ Lenstec, Inc.
Request Sample Report
◍ Hospitals
◍ Ophthalmology Clinics
◍ Ambulatory Surgery Centers
◍ Intraocular Lens (IOL)
◍ Ophthalmic Viscoelastic Device (OVD)
◍ Phacoemulsification Equipment
Request Sample Report
Request Sample Report
$ X Billion USD